First Tracks Biotherapeutics (HAM:B43) EV-to-FCF: (As of Jul. 13, 2026)


HAM:B43 First Tracks Biotherapeutics Inc HAM:B43
20 GF Score
Price €32.00
! 3 Warning Signs
View Full Analysis

What is First Tracks Biotherapeutics EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, First Tracks Biotherapeutics's Enterprise Value is €858.84 Mil. First Tracks Biotherapeutics does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate First Tracks Biotherapeutics's EV-to-FCF at this moment.

The historical rank and industry rank for First Tracks Biotherapeutics's EV-to-FCF or its related term are showing as below:

HAM:B43' s EV-to-FCF Range Over the Past 10 Years
Min: -7.75   Med: 0   Max: 0
Current: -7.75
HAM:B43's EV-to-FCF is ranked worse than
100% of 329 companies
in the Biotechnology industry
Industry Median: 15.61 vs HAM:B43: -7.75

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-13), First Tracks Biotherapeutics's stock price is €32.00. First Tracks Biotherapeutics does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024. Therefore, GuruFocus does not calculate First Tracks Biotherapeutics's PE Ratio (TTM) at this moment.

First Tracks Biotherapeutics  (HAM:B43) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

First Tracks Biotherapeutics's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.00/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

First Tracks Biotherapeutics EV-to-FCF Related Terms

First Tracks Biotherapeutics EV-to-FCF Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics EV-to-FCF Chart

First Tracks Biotherapeutics Annual Data
Trend Dec23 Dec24
EV-to-FCF
0.00 0.00

First Tracks Biotherapeutics Semi-Annual Data
Dec23 Dec24
EV-to-FCF 0.00 0.00

HAM:B43 vs ALT, RGNX, MDXG: EV-to-FCF Comparison

For the Biotechnology subindustry, First Tracks Biotherapeutics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

First Tracks Biotherapeutics EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, First Tracks Biotherapeutics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where First Tracks Biotherapeutics's EV-to-FCF falls into.


HAM:B43
20GF Score
First Tracks Biotherapeutics Inc HAM:B43
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

First Tracks Biotherapeutics EV-to-FCF Calculation

First Tracks Biotherapeutics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=858.838/
=

First Tracks Biotherapeutics Business Description

Other Exchanges TRAX:USA
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
20GF Score

Get the complete analysis for HAM:B43

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.00
Price